ketanserin has been researched along with Alcoholic Liver Diseases in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibson, PR | 1 |
| Fraser, JR | 1 |
| Colman, JC | 1 |
| Jones, PA | 1 |
| Jennings, G | 1 |
| Dudley, FJ | 1 |
1 trial available for ketanserin and Alcoholic Liver Diseases
| Article | Year |
|---|---|
Change in serum hyaluronan: a simple index of short-term drug-induced changes in hepatic sinusoidal perfusion.
Topics: Aged; Hemodynamics; Humans; Hyaluronic Acid; Ketanserin; Liver Circulation; Liver Diseases, Alcoholi | 1993 |